{"id":"https://openalex.org/W2249448939","doi":null,"title":"A phase I and pharmacokinetic study of a CanAg-targeted immunoconjugate, HuC242-DM4, in patients with CanAg-expressing solid tumors","display_name":"A phase I and pharmacokinetic study of a CanAg-targeted immunoconjugate, HuC242-DM4, in patients with CanAg-expressing solid tumors","publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W2249448939","mag":"2249448939"},"language":"en","primary_location":{"id":"mag:2249448939","doi":null,"is_oa":false,"landing_page_url":"http://mct.aacrjournals.org/content/6/11_Supplement/B70","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008969784","display_name":"Kamalesh Kumar Sankhala","orcid":"https://orcid.org/0009-0008-3351-0580","observed_orcids":["https://orcid.org/0009-0008-3351-0580"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamalesh K. Sankhala","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":"https://orcid.org/0009-0008-3351-0580","affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000961519","display_name":"Alain C. Mita","orcid":"https://orcid.org/0009-0009-3260-4793","observed_orcids":["https://orcid.org/0009-0009-3260-4793","https://orcid.org/0000-0002-5387-0160"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alain C. Mita","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":"https://orcid.org/0000-0002-5387-0160","affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112210859","display_name":"Alejandro Daniel Ricart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro D. Ricart","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109341340","display_name":"Monica M Mita","orcid":"https://orcid.org/0009-0004-8448-4854","observed_orcids":["https://orcid.org/0009-0004-8448-4854"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica Mita","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110302492","display_name":"Chia Chi Lin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chia Chi Lin","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103362181","display_name":"Leslie Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Wood","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057503413","display_name":"John Sarantopoulos","orcid":"https://orcid.org/0009-0002-4395-136X","observed_orcids":["https://orcid.org/0009-0002-4395-136X"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Sarantopoulos","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045286901","display_name":"Chris H.M. Takimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris H. Takimoto","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070570779","display_name":"Amita Patnaik","orcid":"https://orcid.org/0000-0002-4144-2193","observed_orcids":["https://orcid.org/0000-0002-4144-2193"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amita Patnaik","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":"https://orcid.org/0000-0002-4144-2193","affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009666113","display_name":"Albert Qin","orcid":"https://orcid.org/0000-0001-7610-084X","observed_orcids":["https://orcid.org/0000-0001-7610-084X"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Albert Qin","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090956548","display_name":"Sybil H Zildjian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Zildjian","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019450412","display_name":"Anthony Tolcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Tolcher","raw_affiliation_strings":["Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, South Texas Accelerated Research Therapeutics, San Antonio, TX, ImmunoGen Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210119066"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210119066"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.20376967,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"6","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6884999871253967,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6884999871253967,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.15629999339580536,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.052799999713897705,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carcinoembryonic-antigen","display_name":"carcinoembryonic antigen","score":0.8889999985694885},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7630000114440918},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9570000171661377},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.7360000014305115},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8989999890327454},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9440000057220459},{"id":"https://openalex.org/keywords/ocular-toxicity","display_name":"ocular toxicity","score":0.9309999942779541},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8983147144317627},{"id":"https://openalex.org/C2778556491","wikidata":"https://www.wikidata.org/wiki/Q1660173","display_name":"Immunoconjugate","level":4,"score":0.6118778586387634},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5549778342247009},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5473466515541077},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5271846055984497},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.4935554265975952},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4821295738220215},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42517024278640747},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.42404067516326904},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4145136773586273},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3810873031616211},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37213993072509766},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.372079998254776},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.20892947912216187},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.16371330618858337},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11678531765937805}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2249448939","doi":null,"is_oa":false,"landing_page_url":"http://mct.aacrjournals.org/content/6/11_Supplement/B70","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2097014638","https://openalex.org/W2980582462","https://openalex.org/W2268378753","https://openalex.org/W2301787994","https://openalex.org/W2121080375","https://openalex.org/W2046737947","https://openalex.org/W2242417477","https://openalex.org/W3024336053","https://openalex.org/W6927566973","https://openalex.org/W1977301054"],"abstract_inverted_index":{"B70":[0],"Background":[4],":":[5],"HuC242-DM4":[6,415],"is":[7,23,205,373,377,385],"a":[8,47,98,332,345,466],"novel,":[9],"targeted":[10],"anti-cancer":[11],"agent":[12,42],"in":[13,138,200,352,459,472],"development":[14],"for":[15,229],"the":[16,26,29,36,139,321,364,371,381,417,436,451],"treatment":[17,228,292],"of":[18,28,50,79,108,183,278,281,291,295,307,334,336,341,347,383,400],"CanAg-expressing":[19,51,70,461,479],"tumors.":[20],"The":[21,152,192],"compound":[22],"formed":[24],"by":[25,181],"conjugation":[27],"potent":[30],"cytotoxic":[31],"maytansinoid":[32],"drug,":[33],"DM4,":[34],"to":[35,158,198,265,287,301,318,402,434,447,453],"humanized":[37,403],"monoclonal":[38],"antibody,":[39],"huC242.":[40],"This":[41],"was":[43,179],"highly":[44],"active":[45],"across":[46],"broad":[48],"spectrum":[49],"human":[52],"tumor":[53,313,462],"xenograft":[54],"models.":[55],"Methods:":[57],"Patients":[59,118],"were":[60,93,112,235,243,262],"enrolled":[61,113,137,211,449],"with":[62,95,355,440,457,470,474],"metastatic":[63],"or":[64,311,406],"inoperable":[65],"colorectal,":[66],"pancreatic,":[67],"and":[68,130,149,177,239,293,344,380,397,429,443,476],"other":[69,150,460],"tumors":[71],"who":[72,261],"have":[73,196,272,315],"failed":[74],"standard":[75],"therapy":[76],"(about":[77],"95%":[78],"pts.":[80],"had":[81],"received":[82,119,273],"\u2265":[83],"4":[84,240,280,297],"prior":[85],"chemotherapy":[86],"regimens).":[87],"Results:":[89],"Thirty-six":[91],"patients":[92,110,185,201,208,249,260,271,284,298,353,439,473],"treated":[94,186,250],"huC242-DM4,":[96],"receiving":[97],"single":[99],"intravenous":[100],"(IV)":[101],"infusion":[102],"once":[103],"every":[104,164],"three":[105,165,289],"weeks.":[106,166],"Cohorts":[107],"3":[109,238,294],"initially":[111],"on":[114,286,300],"each":[115],"dose":[116,155,217,256,263,326,369,422,431],"level.":[117],"huC242-DM4":[120,335,384,458,471],"at":[121,187,212,251,274,303,363,416,450],"18(3":[122],"pts),":[123,144],"36(3),":[124],"60(3),":[125],"90(3),":[126],"126(3),":[127],"168(14),":[128],"223(6),":[129],"297(1)":[131],"mg/m":[132,161,189,214,253,267,323,366,419],"2":[133,162,182,190,215,254,268,324,350,367,388,420],".":[134,191,389],"Tumor":[135],"histologies":[136],"study":[140,469],"included":[141],"colon/colorectal":[142],"(27":[143],"rectal":[145],"(5),":[146],"pancreatic":[147,441],"(2),":[148],"(2).":[151],"maximum":[153],"tolerated":[154],"(MTD)":[156],"appears":[157,433],"be":[159,435,448],"168":[160,213,266,322,365,418],"Dose":[167],"limiting":[168],"toxicity":[169],"(DLT)":[170],"including":[171],"decreased":[172],"visual":[173],"acuity,":[174],"corneal":[175],"deposits":[176],"keratitis":[178],"experienced":[180],"6":[184],"223":[188],"ocular":[193,230],"adverse":[194],"events":[195],"appeared":[197],"improve":[199],"where":[202],"follow-up":[203],"data":[204,330],"available.":[206],"Additional":[207,438],"are":[209,445],"being":[210],"level":[218,257,327,423,432],"using":[219],"preservative-free,":[220],"lubricating":[221],"eye":[222],"drops":[223],"as":[224],"an":[225,425],"exploratory":[226],"preventive":[227],"toxicity.":[231],"In":[232,464],"addition,":[233,465],"there":[234],"12":[236],"grade":[237],"AEs":[241],"that":[242],"considered":[244],"likely":[245],"drug-related.":[246],"Of":[247],"sixteen":[248],"the168":[252],"(including":[258],"two":[259,276],"reduced":[264],"),":[269],"11":[270,283],"least":[275,304],"cycles":[277,290,306],"treatment.":[279,308],"these":[282,296],"went":[285,299],"receive":[288,302],"four":[305],"No":[309],"partial":[310],"complete":[312],"responses":[314],"been":[316,392,410,482],"observed":[317],"date.":[319],"At":[320],"preliminary":[328],"pharmacokinetic":[329],"reveal":[331],"half-life":[333,372],"about":[337],"5":[338],"days,":[339,375],"Cmax":[340,376],"105.8":[342],"ug/mL,":[343,379],"clearance":[346,382],"16.7":[348],"mL/h/m":[349,387],"(9)":[354],"low":[356],"plasma":[357],"CanAg":[358],"levels":[359],"(":[360],"900":[361],"units/mL)":[362],"level,":[370],"2.5":[374],"62.5":[378],"46.1":[386],"There":[390],"has":[391,409,424,481],"no":[393,398],"clinically":[394],"significant":[395],"myelosuppression":[396],"formation":[399],"antibody":[401,404],"(HAHA)":[405],"drug":[407],"(HADA)":[408],"observed.":[411],"Conclusions:":[413],"acceptable":[426],"safety":[427],"profile":[428],"this":[430],"MTD.":[437],"cancer":[442],"cholangiocarcinoma":[444],"planned":[446],"MTD":[452],"gain":[454],"more":[455],"experience":[456],"types.":[463],"phase":[467],"II":[468],"gastric":[475],"gastroesophageal":[477],"junction":[478],"cancers":[480],"initiated.":[483]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}